Selenium for Immune Function
Selenium earns a weak (C) grade for immune function: it matters when you are deficient, but in well-nourished adults there is no good evidence that extra selenium strengthens immunity or lowers infection risk. Because most healthy people already get enough from food, routine supplementation is not warranted and high doses carry real risks.
Why this grade7-layer evidence engine
Selenium is genuinely essential for immune cells: its selenoproteins support T-cell, NK-cell and macrophage function, and deficiency clearly impairs them. Mechanistic work in selenium-deficient mice (PMID 12730444) shows that low selenium lets normally mild coxsackievirus B3 and influenza A mutate into more virulent strains, and review evidence (PMID 22381456, PMID 30200430) confirms poor selenium status tracks with weaker immunity. That biology is solid, which keeps the grade from falling lower.
But the benefit is almost entirely confined to people who start out short on selenium. The same reviews describe a U-shaped curve where replete individuals gain nothing extra and may even face a type-2-diabetes signal at high intake. In randomized trials this gap is stark: a Cochrane review of 10,325 adults with HIV (PMID 28518221) found no effect on mortality or disease progression, and trials in Rwanda (PMID 25870994) and Tanzania (PMID 18541571) moved a CD4 surrogate at best while showing no viral-load benefit and even a fetal-death harm signal. In healthy men, the only human trial (PMID 11575678) had just 11 participants and showed no flu-vaccine benefit.
Regulators and clinics reinforce the caution. The WHO notes selenium helps only as deficiency-zone prophylaxis with "little or no therapeutic value" once disease sets in, and Harvard states that for anyone not at risk of deficiency "there is no evidence" that more selenium delivers the immune benefits on supplement labels (NIH, Cleveland Clinic and CDC agree diet usually suffices). EFSA's approved "normal immune function" wording reflects selenium's nutritional role, not a treatment claim. With excess intake risking selenosis and a drug-interaction flag for immunosuppressants, the verdict stays weak.
Scoring transparency
All scores computed by a 7-layer evidence engine — fully auditable▸View the full decision path (audit trail)
- compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.625
- tier_from_score — 依分數區間映射至 tier letter
- apply_hec_rules — 高品質 SR/MA 顯示 positive (2 篇 > 0 negative)
- tier_strict_requirement_check — | B→C 因 scope.conflation_risk=true 且 L11 獨評較低 (B7-2 tier cap)
- detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
- decide_status — 依 tier + dispute 結果決定 status